| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |